John  O'Bryan  to  Biological Products
                            
                            
                                This is a "connection" page, showing publications  John  O'Bryan  has written about  Biological Products.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.858
         
        
        
     
 
    
        
        - 
            Targeting the "undruggable" RAS with biologics. Adv Cancer Res. 2022; 153:237-266.
            
            
                Score: 0.675
            
         
        
        - 
            Inhibition of RAS-driven signaling and tumorigenesis with a pan-RAS monobody targeting the Switch I/II pocket. Proc Natl Acad Sci U S A. 2022 10 25; 119(43):e2204481119.
            
            
                Score: 0.183